Janssen Demonstrates Its Commitment to Advancing Transformat

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 13 company-sponsored data presentations from its multiple...

Related Keywords

Florida , United States , West Palm Beach , Prinzj Ponesimod , Jessica Moore , Bill Martin , None Of The Janssen Pharmaceutical Companies , Genentech , Americas Committee For Treatment , Janssen Pharmaceuticals Inc , National Multiple Sclerosis Society , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Actelion Pharmaceuticals Ltd , Exchange Commission , Companies Of Johnson , Idorsia Pharmaceuticals Ltd , Research In Multiple Sclerosis , Johnson , Multiple Sclerosis , Global Therapeutic Area Head , Janssen Research , Data Presentations Include , Patient Perspectives , Patient Burden Related , Hidden Symptoms , Novel Patient Recruitment Strategy , Up Front Matching , Mimic Randomization , Phosphate Receptor , Relapsing Forms , Long Term Pooled Safety Results From , Clinical Development , Its Application , Clinical Outcome Assessment , Disease Modifying Therapy , Patients With Relapsing Multiple Sclerosis , Results From , Ponesimod Compared With Teriflunomide , Female Patients With Relapsing Multiple , Patients Treated With , Cingulum Demyelination , First Dose Cardiac Observation , Patients Taking , Real World Study Characterizing Impact , Patient Symptom Recall , Adults With Relapsing Multiple , Systematic Literature Review , Patient Reported Fatigue , Disease Modifying Therapies , Treatment Decision , Starter Pack , Posterior Reversible Encephalopathy Syndrome , Janssen Pharmaceuticals , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Report , Ther Adv Chronic , Multiple Sclerosis Society , Mult Scler Relat , Janssen Pharmaceutical Companies Of Johnson Amp ,